Objectives: to compare the efficacy and cost-effectiveness of ultrasound-guided compression (UGC) with ultrasoundguided thrombin injection (UGTI) for treatment of postcatheterisation arterial false aneurysms (cFA
Introduction
patients with cFA treated with ultrasound-guided percutaneous injection of thrombin. 4 This report was Postcatheterisation false aneurysms (cFA) occur in less quickly followed by several similar publications. [5] [6] [7] [8] [9] [10] Subsequently, various concerns have been raised rethan 1% of cases. 1 Poor puncture-site selection, use of large-bore needles and sleeves, interventional pro-garding possible complications of this treatment, e.g. thromboembolic or allergic reactions. 11, 12 We reviewed cedures, periprocedural use of anticoagulant and antithrombotic agents, poor control of the puncture-site our experience with both treatment modalities and evaluated the efficacy and cost efficiency of UGC vs bleeding upon retrieval of the catheter as well as calcified arteries are all associated with an increased UGTI. rate of this complication. cFA was treated surgically until 1991 when ultrasound-guided compression-closure (UGC) was introduced.
2 UGC rapidly replaced surgery as the treatment modality of first choice, although the success rate was only about 75% and Materials and Methods it had several limitations, including significant local discomfort and a significant rate of recurrence. In 1986 All patients with suspected cFA were evaluated by Cope et al. reported percutaneous injection of thrombin diagnostic duplex scan in our noninvasive vascular to treat false aneurysms, with occlusion of the feeding laboratory with an ultrasound scanner (Synergy, Genvessel. blood flow of all extremities. All patients with cFA with a luminal diameter larger than 1.5 cm were con-next morning to confirm complete obliteration. In a few cases of obese patients or huge haematomas we sidered for non-invasive treatment. Patients with smalexperienced exceptionally poor visualisation of the ler cFA were followed by repeat duplex scans till needle tip by duplex. Subsequently we used specially spontaneous obliteration of the aneurysm and were designed needles with echogenic tips (Echotip, 21-excluded from this study.
gauge 10-centimetre long needle, Cook, Bloomington, Between July 1999 and February 2001 we pro-IN, U.S.A.) that enabled more reliable confirmation spectively collected data on 33 consecutive patients of proper positioning of the needle tip inside the diagnosed with cFA that were treated by UGTI. This aneurysmal sac. group included 6 patients from other hospitals referred for UGTI in our institution. We compared this group to a historic control group of 33 consecutive patients with cFA that were treated with UGC between June Results 1997 and June 1999. We reviewed the charts, noninvasive vascular laboratory findings and outpatient
Comparison of the treatment groups follow-up records of all patients.
UGC was performed in a routine fashion under The UGC and UGTI groups were similar with regard continuous ultrasonographic guidance as previously to age (66 vs 65 years) and male to female distribution described by Fellmeth et al. 2 Briefly, compression of (15:18 vs 14:19, respectively). There were no significant the aneurysmal neck to arrest flow in the cFA sac was differences between the treatment groups regarding applied for 15 min, up to 3 times in sequence, during underlying medical conditions, e.g. ischaemic or one treatment session. If obliteration of the cFA was rheumatic heart disease, hypertension, cigarette smoknot achieved the same procedure was repeated the ing and hyperlipidaemia. The groups were comparable following day, up to a maximum of three sessions. regarding the ratio of interventional vs diagnostic Analgesics and sedative premedication were routinely procedures, and cardiac vs peripheral catheterisations. required to ease the discomfort during the procedure All cFA were of the femoral artery, except 2 cases of and enable effective compression. Anticoagulant and brachial artery cFA in the UGTI group. The median anti-platelet treatments were regularly discontinued diameter of the cFA was 2.37 cm (range: 1.50-5.25 cm) to facilitate successful thrombosis of the aneurysms. in the UGC group and 2.25 cm (range: 1.50-4.53 cm) Patients rendered unsuitable for UGC and patients in the UGTI group. that failed UGC were operated.
UGTI was performed according to the method previously described by Kang et al. 5 Bovine thrombin Ultrasound-guided compression solution (GENTRAC Inc., Middleton, WI, U.S.A.), at a concentration of 1000 u/m after reconstitution of Treatment by UGC was considered in 33 consecutive thrombin powder in sterile normal saline, was drawn patients (Table 1) . One patient died prior to treatment into a 2-millilitre syringe attached to a 21 or 22-gauge and in 2 patients UGC could not be performed due to spinal needle. The skin was prepped with chlorunderlying medical conditions, e.g. severe obesity and hexidine gluconate 0.5% in alcohol 70% solution and unstable cardiac condition. In 26/30 (87%) UGC was the needle was inserted into the cFA under continuous successful, though in 19/30 (63%) more than one sonographic guidance with the color-flow turned off.
session of compression was required. No systemic With the tip of the needle inside the aneurysmal lumen complications have been reported, though the vast and the color-flow turned on, thrombin solution was majority of the patients had large groin hematomas gently injected, resulting in a visible acoustic noise on that resolved spontaneously. One out of 6 patients that the screen. Obliteration of the cFA was detected by required surgery had a prolonged hospitalisation due complete disappearance of the color-flow signal inside to a severe operative wound infection. No late failures the cFA, usually within a few seconds, and the needle were revealed. was removed. If obliteration of the cFA lumen failed, 1-2 similar doses of thrombin were repeatedly injected. We did not apply any local compression and remarkably none of the patients required any analgesic Ultrasound-guided thrombin injection or sedative treatment. Anticoagulant and anti-platelet medication was not modified in this group. All patients Thirty-three consecutive patients with cFA were offered UGTI as the first treatment modality (Table  were kept 
1). UGTI was applicable and resulted in complete
Cost analysis obliteration of the cFA in all patients (100%). In 26/33 (79%) the cFA thrombosed completely during the ini-We performed a limited cost analysis based on local charges (expressed in US$) for non-invasive vascular tial treatment session and only 6/33 (18%) required a second session of UGTI. In addition, one patient with laboratory, operating room, hospitalisation and thrombin, but excluding other charges, e.g. surgeons' fee. a brachial cFA that completely obliterated initially was found with a patent cFA on next day evaluation and Time utilisation of the noninvasive vascular laboratory was more than twice in the UGC group compared to required repeated UGTI. One patient with superficial skin infection in the groin required treatment with the UGTI group. Failure to obliterate most of the cFA by UGC on the first session required an additional oral antibiotics. No adverse reactions of immunologic origin or any other systemic complications have oc-day of hospitalisation for those patients. Six patients in the UGC group required surgery (average 1.5 h curred. Two patients reported transient pain of a few seconds' duration distal to the injection site im-operating room per case) that was followed by an average post-operative hospital stay of 6.7 days per mediately following thrombin injection. Careful examination of the peripheral pulses and doppler studies patient, a relatively prolonged period that resulted from a significant operative wound infection in one of the extremities did not detect any objective signs of embolisation. Unlike in the UGC group, this procedure of the patients. The success in obliterating most cFA by UGTI on the first session and the fact that none was associated with minimal discomfort of the 21-gauge needle stick and resulted in a uniform pattern of the patients in the UGTI group required surgery translated to significant cost savings in this group, of patient satisfaction. No late failures were revealed.
about US$517/patient, or 45% relative cost reduction (Table 2) .
Statistical analysis
We compared the proportion of successful treatment among the two study groups, using Fisher's exact test. Discussion This test is appropriate due to the relatively small size of the study and the small expected frequency. The UGC has been judged to be effective with a success rate of up to 88% in a recent study. 14 Nevertheless, overall success rate of UGTI reached statistical difference compared to UGC (p=0.0460). The difference surgical intervention is still required in failed cases.
UGC is often associated with considerable discomfort in favor of UGTI in achieving fast cure during the first treatment session was highly significant (p<0.0001).
to the patient, it requires repeat duplex studies and relatively prolonged noninvasive vascular laboratory embolisation could be detected by physical examination or doppler studies, we speculated that those utilisation.
The initially published series on UGTI revealed its symptoms could have been caused by possible microemboli that rapidly lysed due to normal thrombolytic excellent success rate but failed to deal convincingly with the concerns of thromboembolic or other systemic reactions in the circulation.
We were also puzzled by the case of a patient with complications, e.g. allergic reactions. A report on a thromboembolic complication of UGTI for a brachial a brachial cFA that ''recanalised'' on repeat duplex 24 h following successful UGTI, without evidence of artery cFA 11 and a report on a case of extensive femoral artery thrombosis following UGTI of a femoral cFA re-bleeding or embolisation. A second attempt of UGTI resulted in complete obliteration of the cFA. We spec-(unpublished communication) further emphasised the significance of those concerns.
ulated that a factor such as the size of the needle-hole, the configuration of the aneurysm and its neck, or We compared the results of UGTI in a prospective consecutive series of patients to the results of UGC in an undetected coagulation abnormality could have contributed to this outcome. Because lack of any oba historic control group of consecutive patients treated previously in our hospital. Unlike in prospective ran-jective evidence of detectable arterial embolisation, we did not alter our approach and continue to offer UGTI domised trials a selection bias can not be completely excluded in this study, yet the results are in agreement as the first treatment modality for patients with cFA.
Nevertheless, we initiated a study to elucidate the with those previously published in the literature. We feel that the importance of those results in a new haemodynamic and pharmacologic mechanisms involved in this novel procedure. treatment modality outweight the shortcomings of the study design.
There was a significant variability in the amount of thrombin required to achieve obliteration of the cFA, At the initiation of UGTI in our institution we carefully monitored each procedure with particular partially due to inter-operator variation. According to the experience of the senior author (EEW) 100-200 attention to possible thromboembolic complications. Precise visualisation of the tip of the injecting needle units of thrombin are usually sufficient to induce thrombosis, though occasionally a second injection is inside the lumen of the cFA was an absolute condition before injection of thrombin. Thrombin was very required, particularly when there is more than one ''loculation'' of the cFA. gently injected to avoid from a possible jet of the solution to reach the lumen of the native artery.
Taylor et al. 7 compared UGTI to UGC and demonstrated significant reduction in cost for this proAll patients were screened for history of allergy, or exposure to thrombin during former cardiovascular cedure, yet the hospital charges were not influenced significantly because their patients required continued surgery. We also prepared ourselves to treat possible systemic reactions, as recently suggested. 12 Two of our hospitalisation due to their severe illnesses. In our study significant cost savings resulted from the fact patients reported on sudden pain of a few seconds' duration in their legs, just distal to the injection site. that none of the patients in the UGTI group required surgery and post-operative hospitalisation. Gaining Although no objective evidence for possible arterial 
